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Human keratinocytes express ETA receptors and produce endothelin-1 (ET-1), which stimulates growth response. Previ-
ously, we reported that a twofold increase in ETA receptors is present in human papillomavirus type 16 (HPV16) immortalized
keratinocytes and that ET-1 induces enhanced proliferative response in these cell lines compared to normal cells. The
present studies examine whether the E5 gene of HPV16 is responsible for the enhanced activity of ET-1 in HPV-transfected
keratinocytes. The presence of the E5 gene in growth factor-starved keratinocytes induced the DNA synthesis and enhanced
the mitogenic activity of ET-1 or epidermal growth factor. The selection of primary keratinocytes in growth factor-free medium
with the addition of ET-1 as a growth factor showed that E5-transfected keratinocytes were able to grow and to form a higher
number of larger colonies with respect to untransfected cells. This effect seems to be related to the interaction of E5 with
the mitogenic signaling pathway of ET-1 rather than to an increase in the expression of the receptors for ET-1. In conclusion,
our data demonstrate that E5 enhances ligand signaling in keratinocytes outside the EGF pathway by the amplification of the
proliferative effect of ET-1/ETA receptor signaling. © 1998 Academic Press
Of the genital human papillomaviruses (HPVs), HPV
type 16 (HPV16) and HPV18 are associated with over 90%
of cervical carcinomas (15, 24). HPV16 DNA can induce
immortalization and transformation of keratinocytes and
exocervical cells (2, 18). E6 and E7 viral genes interact
with the cellular oncosuppressor genes, p53 and Rb, and
may play an important role in this process (14, 23);
nevertheless, the efficiency of transformation using E6
and/or E7 is lower than that obtained using the whole
genome, suggesting a role for additional HPV genes (6).
HPV transfection affects the keratinocyte responsive-
ness to endogenous growth factors leading to a reduced
requirement for them (5, 17). A specific increase in the
level of epidermal growth factor receptors (EGFR), pos-
sibly increasing their sensitivity to growth stimulation by
EGF, has been detected in HPV type 16 immortalized
human keratinocytes (21). The HPV16 E5 gene encodes
a 83-amino-acid polypeptide and can transform rodent
fibroblasts. Although E5 is unable to immortalize keratin-
ocytes, it does extend the life span of these cells and
exhibits mitogenic activity (21). The oncoprotein E5
seems to play a major role in this process by inhibiting
the degradation of EGFR following the internalization of
the receptor–ligand complex (21). Keratinocytes can pro-
duce many growth factors (9, 13, 16), among which some
sustain cell proliferation through an autocrine loop. En-
dothelins (ETs) are a family of three vasoactive peptides,
termed ET-1, ET-2, and ET-3, having profound cardiovas-
cular, mitogenic, and neuroregulatory functions. ETs in-
duce their biological actions through at least two major
receptor subtypes that belong to the family of G-protein-
coupled receptors: a selective ETA receptor that binds
ET-1 and ET-2 with high affinity but ET-3 with low affinity
and a nonselective ETB receptor that binds all ET isopep-
tides with equal affinity. Human keratinocytes express
ETA receptors and produce ET-1, which stimulates
growth response. The inhibition of basal growth of ker-
atinocytes by a specific ETA antagonist demonstrates
that keratinocyte proliferation may be induced by ET-1
acting as an autocrine growth factor (3). Recently, we
have indicated a new mechanism in the growth control of
immortalized keratinocytes mediated by the ET-1 auto-
crine loop. ET-1 is released from HPV-transfected kera-
tinocytes and induces increased growth response in
these cell lines compared to normal cells. All HPV-trans-
fected cell lines exhibit a twofold increase in ETA recep-
tors compared to parental cells, in the absence of recy-
cling alterations. Furthermore, HPV-transfected keratino-
cytes can proliferate in the absence of any growth factor
added to the culture medium and a specific ET-1 antag-
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onist completely prevents this growth stimulation (22).
These data suggest that the up-regulation of the ET-1
autocrine loop may provide a selective growth advantage
for HPV-infected cells in vivo.
In order to investigate the mechanism by which ETA
receptor steady-state protein levels are elevated, we
evaluated whether some viral protein could be involved
in this overexpression. The absence of increased levels
of ETA receptor in cells transfected with E6–E7 se-
quences (22) suggests that other early genes or a coop-
eration among different viral genes could be involved in
the up-regulation of the ETA receptor. Furthermore, our
previous data showing no significant alteration of the
ET-1 receptor recycling in HPV-transfected keratinocytes
suggest that E5 is not involved in this up-regulation, at
least by mechanisms acting for EGF up-regulation (21).
Nevertheless the E5 gene could be involved in this
up-regulation by increasing the expression of other
genes downstream in the signaling pathway cascade (8,
10). Moreover E5 cooperates with E7 to stimulate cell
proliferation (7) and with the complete viral genome to
enhance the immortalization of keratinocytes (20). There-
fore, in the present study we evaluated whether the E5
protein of HPV16 might enhance the sensitivity of primary
human keratinocytes to ET-1 growth stimulation.
Normal human epidermal keratinocytes (NHEK) were
isolated from child foreskins essentially as described by
Pirisi et al. (18) except that the epidermis was separated
from the derma by overnight digestion with 0.25% trypsin
(GIBCO, Glasgow, Scotland). All cell lines were main-
tained, with medium change every 48 h, in keratinocyte
serum-free medium (KSFM, GIBCO) with EGF (5 ng/ml)
and bovine pituitary extract (BPE) (35–50 mg protein/ml).
These keratinocytes were transfected via lipofection with
the plasmid pMHPV16d consisting of a head-to-tail
HPV16 DNA dimer cloned into the pdMMTneo plasmid (a
gift of J. di Paolo, Bethesda, MD), or the recombinant
plasmid pRepE5, or the control plasmid (as stated in
each experiment). The pRepE5 plasmid was obtained by
subcloning the HPV16–E5 open reading frame (ORF)
from the BSK/E5 plasmid containing the complete ORF of
the HPV16 E5 gene (a gift of M. Tommasino, Heidelberg,
Germany) into the pRep10 (Invitrogen, The Netherlands)
expression vector downstream of the RSV-LTR promoter
and upstream of the SV-40 polyadenilation signal. Briefly,
5 mg of plasmid mixed to 30 mg of DOTAP (Boerhinger
Mannheim, Germany) in a final volume of 200 ml was
added dropwise to keratinocytes grown to subconflu-
ence in 60-mm petri dishes. After 24 h the DNA mixture
was removed and fresh medium was added. All the
subsequent experiments were done shortly after trans-
fection. The transfection efficiency was assayed by mea-
suring b-galactosidase activity in the presence of X-Gal
(5-bromo-4-chloro-3-indolyl-b-D-galactopiranoside) upon
cotransfection with 2 mg of a b-Gal gene expressing
plasmid. Under these conditions about 30% of keratino-
cytes were transfected.
After transfection with pRepE5 we analyzed the spe-
cific transcripts for E5 and ETA receptor by reverse tran-
scription (RT)–PCR. One microgram of RNA was reverse
transcribed to cDNA and amplified by the RNA PCR Kit
(Perkin–Elmer Co.) according to the manufacturer’s in-
structions, with specific primers for the ETA receptor (1)
and with primers flanking bp 3873 to 4110 of the HPV16
genome for the E5 ORF. The ETA-specific mRNAs were
detectable in transfected keratinocytes as well as those
for the E5 ORF (Fig. 1). As reported for normal and
HPV16-transfected keratinocytes, the presence of the
ETA receptor indicates that ET-1 can exert its mitogenic
action through this specific receptor (22). To evaluate the
proliferative effects of ET-1 on keratinocytes transfected
by the E5 gene we measured [3H]thymidine incorpora-
tion in normal and E5 transfected keratinocytes. In this
assay, cells were seeded in 96-well plates at approxi-
mately 80% confluence (2 3 104 cell/well) and incubated
in growth factor-free medium for 24 h to induce quies-
cence. Selected concentrations of ET-1, BQ 123, and EGF
were then added, and after 18 h, the cell-associated
radioactivity was determined by liquid scintillation count-
ing. The BQ 123 is a selective ETAR antagonist and has
no effect on EGF stimulation of keratinocyte proliferation
(22). Due to the known mitogenic properties of HPV16 E5,
keratinocytes expressing the E5 gene displayed an in-
creased DNA synthesis with respect to controls (Fig. 2).
Straight et al. (21) reported a similar effect with a different
construct in a transitory mitogenesis assay. The basal
[3H]thymidine incorporation of normal and E5-trans-
fected keratinocytes in growth factor-free medium was
inhibited by the presence of the ETAR antagonist, BQ123,
demonstrating that endogenous ET-1 may act as an
autocrine regulator of E5-transfected keratinocyte prolif-
eration.
FIG. 1. Detection of ETAR and E5 mRNA by RT–PCR. Total RNA was
extracted from normal (N) and pRepE5 (E5)-transfected cells. cDNA
was generated using 1 mg of total RNA as template. PCR was per-
formed with primer pairs for ETAR, glyceraldheyde-3-phosphate dehy-
drogenase (GAPDH) and E5 ORF, as indicated at the top of the lanes.
B is the blank reaction with no RNA added. Ethidium bromide-stained
gel of the amplified products.
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As expected, exogenous ET-1 activated mitogenic sig-
nals in normal and E5-transfected keratinocytes. The
DNA synthesis was comparable to that induced by EGF,
confirming that, for keratinocytes, ET-1 is equipotent to
EGF in growth stimulation. When the quiescent keratin-
ocytes were treated with ET-1 and EGF together, a less
than additive response was observed. If one compares
E5-transfected cells to cells not transfected, the stimula-
tion was 1.4-fold in the absence of any added growth
factor. This ratio slightly increased to 1.7 when the
growth factors were added, suggesting the presence of
interactions or partial overlaps between E5 and different
mitogenic signaling pathways (1, 4, 7, 10, 20). The simi-
larity of E5 action on ET-1 or EGF-induced DNA synthesis
allowed us to hypothesize that this E5 construct could
increase the number of ET-1 receptors, as already re-
ported for EGF. To elucidate this point, binding studies of
125I-labeled ET-1 were carried out in keratinocytes trans-
fected with the E5 construct.
Keratinocytes were cultured in 6-well plates until con-
fluent (8 3 105 cells/well) and then serum starved for
24–48 h. A binding assay was performed as described
(22). The number of binding sites was determined by
Scatchard analysis using the LIGAND program. As
shown in Table 1, no difference was detected in E5-
transfected keratinocytes with respect to normal cells,
whereas the full-length genome of HPV16, utilized as a
positive control, caused an increase in the number of
receptors. These data confirm our previous results and
suggest that E5 can interact with the signal transduction
of ET-1 in a way different from that of EGF.
ET-1 promotes the growth of normal and HPV16-trans-
fected keratinocytes in the absence of any other growth
factors (3, 22). Since E5 is able to induce DNA synthesis
and is involved in the growth control of keratinocytes, we
also investigated whether E5 may favor the clonal pro-
liferation of keratinocytes in the absence of growth fac-
tors or in the presence of ET-1 alone.
Cells were seeded at 4 3 105 cells/ml in 60-mm petri
dishes and cultured for 24 h in growth factor-free me-
dium; then quiescent cells were transfected by lipofec-
tion with the appropriate plasmids. After 24 h the DNA
was removed and growth factor-free medium with or
without 1027 M ET-1 was added. After 5 days selection
the cell cultures were trypsinized and seeded in T25
flasks. After 10 days cell colonies were stained with 0.1%
crystal violet in methanol. Proliferating macrocolonies
were measured as reported by Schlegel et al. (19). In the
absence of any growth factor, E5, as well as ET-1 alone,
induced clonal cell proliferation, confirming that E5 ex-
erts mitogenic activity and ET-1 is one of the most im-
portant mitogenic signals for keratinocytes (Fig. 3). Fur-
thermore, the simultaneous presence of ET-1 and E5
produced a dramatic increase (sixfold) in the number
(Fig. 3 panel B) and in the size of proliferating clones,
demonstrating that the action of E5 and ET-1 represents
a potent stimulus for keratinocytes to growth even in the
absence or a low level of growth factors, considering the
possibility of an endogenous production.
Thus, E5 has been shown to be a mitogen for keratin-
ocytes and it cooperates with ET-1 to stimulate [3H]thy-
midine incorporation as well as cell proliferation. This
action apparently occurs through a different pathway
than that observed for EGF, since E5, which is known to
function by increasing EGFR signaling, does not in-
crease the number of ET receptors. The E5 gene is able
to modulate the signal transduction pathway by different
mechanisms (8, 10) and therefore the mitogenic stimulus
caused by E5 produces actively growing cells which may
be more sensitive to the mitogenic signals.
In conclusion we demonstrated that E5 may enhance
the mitogenic activity of autocrine growth factors such as
ET-1, providing a selective growth advantage for HPV-
infected cells in vivo in the early stage of virus infection.
ET-1 is a potent growth factor for keratinocytes and
cooperates with E5, which is known to function by in-
creasing EGFR signaling, in growth stimulation. It is
TABLE 1
Number of ET-1 Receptors in Transfected Keratinocytes
DNA transfected Receptors/cell
pMMTneo 1708 6 70
pMHPV 16d 4125 6 120a
pRep10 1558 6 56
pRepE5 1543 6 58
Note. Binding data are the mean of three experiments each per-
formed in triplicate and analyzed using the LIGAND program.
a P , 0.001 versus pMMTneo.
FIG. 2. Mitogenic effect of ET-1, BQ 123, and EGF on normal and
E5-transfected keratinocytes. Quiescent cells were incubated with
BQ123 (1027 M), ET-1 (1027 M), and EGF (10 ng/ml) for 24 h and
[3H]thymidine incorporation was determined. Data were means of three
independent experiments, each performed in sextuplicate, and SDS
were less than 15% of each value.
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likely that the interaction or convergence of different
mitogenic signal pathways is necessary for the mito-
genic activity of ET-1. Recent studies demonstrate that
ET-1 requires the recruitment of tyrosine kinase path-
ways through a ligand-independent mechanism of EGFR
transactivation in RAT-1 fibroblasts (11). Transactivation
of EGFR has been also proposed as a mechanism re-
sponsible for G-protein-coupled receptor-induced mito-
genic activity in keratinocytes (12), suggesting a major
point toward understanding potential interactions among
E5, ET-1/ETAR expression, and EGF on keratinocyte
growth.
More details of the E5 effect on ET-1 and/or EGF
signaling are needed to clarify the biological relevance of
these interactions in the various aspects of the patholo-
gies associated with HPV infection.
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